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Summary
Synpolydactyly (SPD) is a dominantly inherited congen-
ital limb malformation consisting of 3/4 syndactyly in
the hands and 4/5 syndactyly in the feet, with digit du-
plication in the syndactylous web. The condition re-
cently has been found to result from different-sized ex-
pansions of an amino-terminal polyalanine tract in
HOXD13. We report a novel type of mutation in
HOXD13, associated in some cases with features of clas-
sic SPD and in all cases with a novel foot phenotype. In
two unrelated families, each with a different intragenic
deletion in HOXD13, all mutation carriers have a ru-
dimentary extra digit between the first and second meta-
tarsals and often between the fourth and fifthmetatarsals
as well. This phenotype has not been reported in any
mice with genetic modifications of the HoxD gene clus-
ter. The two different deletions affect the first exon and
the homeobox, respectively, in each case producing
frameshifts followed by a long stretch of novel sequence
and a premature stop codon. Although the affected genes
may encode proteins that exert a dominant negative or
novel effect, they are most likely to act as null alleles.
Either possibility has interesting implications for the role
of HOXD13 in human autopod development.
Introduction
Synpolydactyly (SPD; MIM 186000) is a rare, domi-
nantly inherited limb malformation that typically con-
sists of 3/4 syndactyly in the hands and 4/5 syndactyly
in the feet, with digit duplication in the syndactylous
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web (Temtamy and McKusick 1978). Incomplete pen-
etrance and variable expressivity, both between and
within affected families, are common (Thomsen 1927;
Cross et al. 1968; Sayli et al. 1995). One to four limbs
can be involved, and the severity of involvement varies
from partial skin syndactyly to almost complete digit
duplication, extending proximally as far as the meta-
carpals/metatarsals, which may have a characteristic bi-
fid appearance on radiological examination. Associated
distal limb abnormalities include clinodactyly, campto-
dactyly, or brachydactyly of the fifth fingers and middle
phalanx hypoplasia/aplasia, sometimes with syndactyly,
of the second to fifth toes.
SPD is the first human malformation syndrome shown
to be caused by mutations in a HOX gene, HOXD13
(Muragaki et al. 1996). The mutation in question is spe-
cific and highly unusual. An imperfect trinucleotide re-
peat sequence in exon 1 of the gene, which in normal
individuals encodes a 15-residue polyalanine tract, is ex-
panded, resulting in a tract of 22–29 residues (Akarsu
et al. 1996;Muragaki et al. 1996; Goodman et al. 1997).
Studies of affected families with different-sized expan-
sions show that both penetrance and severity of phe-
notype increase progressively with increasing expansion
size (Goodman et al. 1997). This close correlation, to-
gether with the observation that the limb phenotype of
mice lacking Hoxd13 is strikingly different from that of
humans with SPD (Dolle´ et al. 1993; Davis and Capecchi
1996), has led to the suggestion that expansions of the
polyalanine tract may confer a progressive gain of func-
tion on the mutant protein. This hypothesis is supported
by the finding that mice homozygous for a deletion en-
compassing Hoxd11, Hoxd12, and Hoxd13 have cen-
tral digital fusions and duplications resembling those of
patients with SPD (Za´ka´ny and Duboule 1996), imply-
ing that the mutant HOXD13 protein in SPD may be
exerting a dominant negative effect over the remaining
wild-type HOXD13, as well as over HOXD11 and
HOXD12.
To explore further the role of HOXD13 in human
limb development, we sought to identify patients with
phenotypes similar to that of classic SPD in whom there
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was no evidence of a HOXD13 polyalanine tract ex-
pansion. We now report our findings in two such fam-
ilies, each carrying a different intragenic deletion in
HOXD13 which segregates with distal limb abnormal-
ities. Although some carriers of each deletion showed
features of classic SPD, all deletion carriers from both
families shared a novel foot malformation.
Patients and Methods
Patients
The two families that we report were ascertained after
referral for genetic counseling to the Human Genetics
Service, University of Florence (pedigree 1), and the Clin-
ical Genetics Unit, Great Ormond Street Hospital, Lon-
don (pedigree 2). In each case, the study was undertaken
with the approval of the local ethical review board. Ped-
igree 1 (fig. 1A) was a six-generation Italian family. Dig-
ital abnormalities were initially identified in three family
members: by clinical examination, for individual VI-1
(the proband); by means of an old family photograph,
for individual III-5 (who was unavailable for clinical
evaluation); and on the basis of family reports, for in-
dividual II-3 (who was deceased). Ten additional family
members (indicated in fig. 1A) were subsequently ex-
amined clinically, and radiographs of both hands and
both feet were obtained for five of these individuals (III-
4, IV-2, IV-4, V-3, and V-4). Pedigree 2 (fig. 1B) was a
five-generation Scottish family. Digital abnormalities
were initially identified in seven family members: by clin-
ical examination, for individuals III-2, III-4, IV-2 (the
proband), IV-4, and V-1; and on the basis of family
reports, for individuals II-5 and II-6 (both deceased).
Three additional family members (indicated in fig. 1B)
were subsequently examined clinically. Radiographs of
both hands and both feet were obtained for seven family
members (indicated in fig. 1B). In the case of individuals
III-2, IV-2, and IV-4, who had undergone corrective sur-
gery in childhood, these were postoperative films; for all
three, however, the original extent of the malformation
could be established from old medical records. For both
pedigrees, information about the clinical status of those
family members who were either deceased or unavailable
for examination was sought from the family. Venous
blood samples were obtained from consenting individ-
uals, 13 from pedigree 1 and 11 from pedigree 2 (in-
dicated in figs. 1A and 1B).
Methods
Genomic DNA for mutation analysis was extracted
from whole venous blood samples (QIAamp Blood Kit,
QIAGEN). To screen for expansions of the HOXD13
polyalanine tract, we performed PCR using primers de-
signed to amplify a 172-bp fragment of exon 1 of
HOXD13, which contains the imperfect trinucleotide
repeat sequence encoding the tract. Primers and reaction
conditions were as described elsewhere (Muragaki et al.
1996). Products were analyzed on a 4% agarose gel to
detect the presence of an expanded allele. To search for
mutations elsewhere in the gene, we amplified the entire
HOXD13 coding sequence by PCR in three segments,
using the primers and reaction conditions described else-
where (Goodman et al. 1997). Products either were sub-
cloned into pCRScript (Stratagene) before being cycle
sequenced (Applied Biosystems Prism Dye Terminator
Kit) or were cycle sequenced directly.
After identification of the deletion in the proband from
pedigree 1, mutation screening in other family members
was performed by PCR using sense primer 5′-CA-
GTGCCGCGGCTTTCTCT-3′ and antisense primer 5′-
GACATACGGCAGCTGTAGTAGC-3′. These yielded a
308-bp product starting at base 91 of the coding se-
quence in normal individuals and a second 294 bp prod-
uct in the proband. (Numbering of bases in this report
starts with the first residue of the initiator codon
[GenBank accession numbers AF005219 and
AF005220].) Amplification reactions contained 1# Pfu
buffer (Stratagene), 0.25 mM of each dNTP, 10% glyc-
erol, 2% formamide, 1 mM of each primer, and 0.6 U
of cloned Pfu polymerase (Stratagene) in a final volume
of 25 ml. Initial denaturation was at 97.5C for 2 min,
followed by 30 cycles of denaturation at 97.5C for 30
s, annealing at 61C for 30 s, and extension at 72C for
45 s. PCR products were analyzed on a 4% agarose gel
to detect the presence of the deleted allele.
After identification of the deletion in the proband from
pedigree 2, we performed mutation screening in other
family members, using PCR and restriction site analysis.
We amplified a 335-bp fragment containing exon 2 of
HOXD13, using the primers and reaction conditions
described elsewhere (Goodman et al. 1997). A PstI site
occurs after base 135 of this fragment, which is de-
stroyed by the deletion of the single G residue identified
in the proband. PstI digestion reactions contained 5 U
of PstI (Gibco BRL), 1 # REact 2 buffer (Gibco BRL)
and 50–100 ng PCR product in a final volume of 15 ml.
Digestions were carried out at 37C for 2 h, and the
products were analyzed on a 4% agarose gel.
Results
Mutation Analysis
In each family, initial screening of the proband by PCR
showed that the HOXD13 15-residue polyalanine tract,
which is expanded in all SPD patients studied to date,
was normal in length.
In pedigree 1, sequence analysis of HOXD13 in the
proband revealed a 14-bp deletion in exon 1 (figs. 2A
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Figure 1 A, Pedigree 1. B, Pedigree 2. A horizontal line above a pedigree symbol indicates that the individual was examined clinically.
An asterisk above a pedigree symbol indicates that radiographs of both hands and both feet were obtained. The letter “D” or “N” below a
pedigree symbol indicates that DNA analysis was carried out, which demonstrated that the individual either did (D) or did not (N) carry the
familial deletion. Blackened symbols represent individuals in whom a digital abnormality was identified on clinical examination, present on an
old photograph (III-5 in pedigree 1), or reported by the family (II-3 in pedigree 1, II-5 and II-6 in pedigree 2). Unblackened symbols represent
individuals who had no digital abnormality on clinical examination or according to family reports. Dotted symbols represent individuals found
to be normal on clinical examination but mutation carriers on DNA analysis, or, in the case of II-2 and III-3 (both deceased) in pedigree 1,
individuals who were unaffected according to the family but were obligate mutation carriers on pedigree analysis. In both families, pedigree
analysis indicated that either I-1 or I-2 was a mutation carrier, although all four individuals (now deceased) were reported to have been
unaffected. Because it is impossible to determine which of these individuals did in fact carry the mutation, all four symbols have been left
unblackened.
and 2B), encompassing bases 323–336 of the coding
sequence. This deletion begins 134 bases downstream of
the end of the imperfect trinucleotide repeat sequence
that encodes the 15-residue polyalanine tract. Interest-
ingly, it affects a region of exon 1 (bases 313–330) that
encodes a second polyalanine tract, in this case only six
alanine residues long. PCR amplification of a 308-bp
fragment of exon 1 containing the 14-bp deleted region
yielded a second, 294-bp product in the proband, thus
providing a simple means of screening other familymem-
bers for the presence of the mutation. In this way, the
deletion was also detected in four additional family
members: III-4, IV-2, IV-4, and V-4 (results not shown).
This deletion creates a frameshift leading to a premature
stop codon at bases 681–683 of the coding sequence,
which would be expected to result in a protein contain-
ing only the first 107 amino acids of the wild-type pro-
tein, followed by 115 amino acids with no counterpart
in the wild-type protein and entirely lacking the hom-
eodomain (fig. 3C).
In pedigree 2, sequence analysis of HOXD13 in the
proband revealed that a single G residue, the 77th res-
idue of exon 2 (base 834 of coding sequence), was de-
leted (figs. 2C and 2D). This deletion destroys a PstI site
in a 335-bp fragment produced by PCR amplification
of the exon. After digestion, the two expected 135-bp
and 200-bp bands were detected in normal individuals,
whereas a third, 335-bp band, representing the uncut
PCR fragment, was also detected in the proband, con-
firming that he was heterozygous for the deletion. Again,
this provided a convenient means of screening other fam-
ily members for the presence of the deletion, allowing
us to identify it in six additional family members: II-4,
III-2, III-4, IV-1, IV-4, and V-1 (results not shown). This
Figure 2 Sequence analysis of the two deletions. A, Bases 310–348 of the wild-type coding sequence. The 14 bases deleted in pedigree 1 (bases 323–336) lie between the two arrowheads. B,
The same sequence in the proband from pedigree 1, showing the site of the deletion (arrowhead). C, Bases 823–843 of the wild-type coding sequence. The single G residue deleted in pedigree 2 (base
834) lies between the two arrowheads. D, The same sequence in the proband from pedigree 2, showing the site of the deletion (arrowhead).
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Figure 3 A, The genomic structure of HOXD13, showing the
sites of the two deletions. B, The wild-type HOXD13 protein. C, The
predicted mutant protein in pedigree 1. The first 107 wild-type amino
acids are followed by 115 amino acids with no counterpart in the wild-
type protein and by a premature stop codon.D, The predicted mutant
protein in pedigree 2. The first 278 wild-type amino acids, including
the first 11 amino acids of the homeodomain, are followed by 33
amino acids with no counterpart in the wild-type protein and by a
premature stop codon.
Table 1
Distal Limb Phenotype in Mutation Carriers
Subject
Novel Foot
Phenotype
3/4 SPD
in Hands
4/5 SPD
in Feet
Pedigree 1:
I-1 or I-2 ? No No
II-2 ? No No
II-3 ? Bilateral ?
III-3 ? No No
III-4 Yes No No
III-5 ? Bilateral ?
IV-2 Yes No No
IV-4 Yes No No
V-4 Yes No No
VI-1 ? Bilateral Unilateral
Pedigree 2:
I-2 or I-2 ? No No
II-4 Yes No No
II-5 ? No Bilateral
II-6 ? No Bilateral
III-2 Yes Bilateral Unilateral
III-4 Yes No Unilateral
IV-1 Yes No No
IV-2 Yes No Bilateral
IV-4 Yes Bilateral Bilateral
V-1 Yes No Unilateral
NOTE.—A question mark (?) indicates that information is
unavailable.
deletion also creates a frameshift, leading to a premature
stop codon at bases 935–937 of the coding sequence.
The resulting protein would be expected to contain only
the first 278 amino acids of the wild-type protein, fol-
lowed by 33 amino acids with no counterpart in the
wild-type protein, and would lack the last 49 amino
acids of the 60–amino acid homeodomain, including the
entire recognition helix (fig. 3D).
To exclude the possibility that polymorphisms or
other mutations in HOXD13 might cosegregate with
the observed deletions and thus influence the phenotype,
the entire mutant allele from one affected individual
from each pedigree (IV-2 from pedigree 1 and III-2 from
pedigree 2) was sequenced and found to be normal, apart
from the deletions already identified (results not shown).
Phenotype Analysis
The distal limb phenotype in mutation carriers from
both families is summarized in table 1. The most striking
finding was a distinctive set of abnormalities present
bilaterally in the feet of all 11 proven deletion carriers
who were available for radiological examination (III-4,
IV-2, IV-4, and V-4 from pedigree 1; and II-4, III-2, III-
4, IV-1, IV-2, IV-4, and V-1 from pedigree 2). Partial
duplication of the bases of the second metatarsals in the
first web spaces was seen in every case, often accom-
panied by a similar duplication of the fourth metatarsals
in the fourth web spaces. In addition, the phalanges of
the halluces were abnormally broad and the first met-
atarsals were often short (figs. 4A and 4B). These fea-
tures constitute a unique dominantly inherited foot phe-
notype that has not been reported previously. In
particular, this phenotype does not occur in patientswith
classical SPD caused by HOXD13 polyalanine tract ex-
pansions and extends as far anteriorly as the first digits,
which are not normally affected in SPD. In addition, the
middle phalanges in the second to fifth toes were often
hypoplastic or fused to the distal phalanges, as some-
times occurs in classical SPD. This novel foot phenotype
is identical in mutation carriers from the two different
pedigrees and appears to be fully penetrant.
The 3/4 finger and 4/5 toe synpolydactyly character-
istic of classical SPD was also noted in some mutation
carriers from both families. In pedigree 1, individuals II-
3, III-5, and VI-1 all had bilateral 3/4 synpolydactyly in
the hands (fig. 4C), but only individual VI-1 had uni-
lateral 4/5 foot synpolydactyly (fig. 4D). (The foot phe-
notype in individuals II-3 and III-5 could not be ascer-
tained.) In pedigree 2, individuals III-2 and IV-4 had
bilateral 3/4 synpolydactyly in the hands (fig. 4E); in-
dividuals II-5, II-6, IV-2, and IV-4 had bilateral 4/5 syn-
polydactyly in the feet; and individuals III-2, III-4, and
V-1 had unilateral 4/5 synpolydactyly in the feet. The
number of mutation carriers studied is too small to allow
Figure 4 The phenotype in deletion carriers from the two pedigrees. A and B, The novel foot phenotype. A, Radiograph of both feet of V-4 from pedigree 1, age 33 years, showing partial
duplication of the proximal second metatarsals in the first web spaces and partial duplication of the proximal fourth left metatarsal in the fourth web space. The distal phalanges of the halluces are
broad, and there is symphalangism of the middle and distal phalanges of the second and fifth toes. B, Radiograph of both feet of II-4 from pedigree 2, age 72 years, showing bilateral partial duplications
of the proximal second and fourth metatarsals in the first and fourth web spaces, respectively. The distal and proximal phalanges of the halluces are broad, and there is hypoplasia of the middle and
distal phalanges of the second to fifth toes. C, D, and E, Features of classical SPD. Photographs of the hands (C) and the right foot (D) of the proband (VI-1) from pedigree 1, age 1 year, showing
bilateral 3/4 syndactyly in the hands and unilateral 4/5 foot syndactyly. E, Radiograph of the hands of IV-4 from pedigree 2, age 25 years, after surgery in childhood to release bilateral 3/4 syndactyly,
showing attempted duplication of the proximal, middle, and distal phalanges of both ring fingers, with soft-tissue syndactyly and bony syndactyly of the distal phalanges.
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firm conclusions to be drawn about levels of penetrance.
Nevertheless, the proportion of mutation carriers with
3/4 synpolydactyly in the hands appears to be similar in
the two families (30% in pedigree 1 and 20% in pedigree
2), whereas the proportion of mutation carriers with 4/
5 synpolydactyly in the feet is higher in pedigree 2 (70%)
than in pedigree 1 (10%–30%). These data also suggest
the intriguing possibility that 3/4 synpolydactyly may be
less common in the hands of carriers of these deletions
than in the hands of carriers of polyalanine tract ex-
pansions. Even in the case of seven-residue expansions
(the smallest expansion known to produce a clinical phe-
notype and the expansion with the lowest penetrance),
58% of carriers have 3/4 synpolydactyly in the hands
(28% have 4/5 synpolydactyly in the feet) (Goodman et
al. 1997).
No mutation carrier in either family had any form of
lower–urogenital tract malformation, although hypo-
spadias has been noted in affected males from one SPD
family with a 14-residue polyalanine tract expansion
(Goodman et al. 1997).
Discussion
The two deletions in HOXD13 reported here are as-
sociated with a novel foot phenotype that is character-
ized by preaxial as well as postaxial polydactyly and
extends as far as digit 1, the extreme anterior border of
HOXD13 function during specification of the autopod
(Nelson et al. 1996). Although mild, this phenotype ap-
pears to be fully penetrant. The more severe features of
classical SPD, 3/4 synpolydactyly in the hands and 4/5
synpolydactyly in the feet, also occur, but at a reduced
penetrance. Since the novel foot phenotype is never
found in patients with classical SPD caused by poly-
alanine tract expansions, it represents a hitherto undes-
cribed extension of the phenotypic spectrum seen in SPD,
presumably resulting from a different perturbation of
HOXD cluster function during autopod development.
Moreover, the two deletions must act by the same or a
very similar mechanism, since they produce virtually in-
distinguishable phenotypes in carriers from the two dif-
ferent families. In principle, the two mutations could
exert their effects by (1) perturbing the ratio of normal
transcripts from the mutant allele; (2) directing the syn-
thesis of abnormal proteins, which then exert a domi-
nant negative or novel effect; or (3) preventing the pro-
duction of any stable protein, thus leading to functional
haploinsufficiency. We consider these three alternatives
in order.
First, a protein with a functional homeodomain could
theoretically still be produced from both mutant alleles.
There are several potential alternative initiator codons
in exon 1 of the gene, and a shorter form of Hoxd13
starting at codon 98 of the longer form has been reported
in developing chick limbs (Goff and Tabin 1997). This
smaller isoform, if it occurs in humans, could still be
produced from alleles carrying the exon 1 deletion, but
this would not be possible in the case of the exon 2
deletion, which directly disrupts the homeodomain. Sec-
ond, alternative splice forms of HOXD13 may exist, as
has been demonstrated for several other mammalian
Hox proteins (Benson et al. 1995; Chariot et al. 1995;
Hong et al. 1995; Fujimoto et al. 1998). In the case of
the exon 1 deletion, a hitherto unidentified 5′ exon could
be spliced to exon 2, whereas in the case of the exon 2
deletion, exon 1 could be spliced to the second, hom-
eobox-encoding exon of the adjacent HOXD12 gene,
in each case permitting synthesis of proteins with func-
tional homeodomains and perturbing the resulting ratio
of HOXD13 isoforms. As yet, however, there is no ev-
idence that more than one initiator codon or splicing
pattern is used in HOXD13. Moreover, both choice of
initiation site and splicing would be affected differently
by the two mutations, and this is difficult to reconcile
with the extremely similar phenotypes that they produce.
The second alternative is that an abnormal protein is
expressed from both mutant alleles. Homeodomain pro-
teins in which the homeodomain has artificially been
partially deleted occasionally retain their capacity for
protein/protein interactions when expressed at high lev-
els (Copeland et al. 1996; Hyduk and Percival-Smith
1996), and transcripts lacking the homeobox have been
reported for several mammalian Hox genes (Chariot et
al. 1995; Fujimoto et al. 1998). The two truncated mu-
tant proteins predicted here might thus exert a functional
effect through their remaining amino-terminal domains.
In both cases, the 15-residue polyalanine tract, expan-
sions of which cause classical SPD, would remain intact.
Given the extreme similarity of the phenotypes pro-
duced, however, such a functional effect would have to
be mediated by only the first 107 wild-type residues (the
region shared by the two mutant proteins), and these
107 residues would have to adopt the same fold when
followed either by 115 novel residues (pedigree 1) or by
171 wild-type residues and 33 different novel residues
(pedigree 2). If this is indeed the case, these initial 107
residues must play a crucial functional role in human
autopod formation.
The final alternative is that no functional protein is
made from either mutant allele. In addition to truncating
the normal protein, both deletions also produce a long
carboxy-terminal tract of nonsense sequence, ending
with a premature stop codon.Most frameshiftmutations
of this kind have been found in practice to act as null
alleles (for examples, see Hanson et al. 1993; Tassabehji
et al. 1995; Willing et al. 1996; Edery et al. 1997), in
part because transcription from the mutant allele is gen-
erally markedly reduced as a result of nonsense-mediated
mRNA decay (Belgrader et al. 1994; Maquat 1995; Ja-
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cobson and Peltz 1996). The two mutant proteins pre-
dicted here are thus unlikely to be synthesized at ap-
preciable levels. Moreover, such tracts of carboxy-
terminal nonsense sequence generally do not adopt a
stable fold, resulting in rapid degradation of the entire
protein (Kalderon 1996). A loss-of-function interpreta-
tion is also easier to reconcile with the observation that
the two different mutant proteins appear to exert the
same functional effect. We therefore favor the alternative
that both mutations act as null alleles, although the other
alternatives cannot at this stage be ruled out.
If this interpretation is correct, the phenotype de-
scribed here represents the first report of functional hap-
loinsufficiency for a HOX gene in humans (unless the
nonsense mutation in HOXA13 recently found in one
family with hand-foot-genital syndrome [Mortlock and
Innis 1997] also proves to inactivate the resulting pro-
tein). At first sight, however, it is inconsistent with the
reported phenotypes of mice in which the HoxD gene
cluster has been genetically modified.
Knockout mice lacking Hoxd13 have been described
by two groups (Dolle´ et al. 1993; Davis and Capecchi
1996). Only 36% of heterozygotes are affected, and
those that are have minor carpal defects and an addi-
tional bony element postaxial to the fifth digit in the
forelimb only. (Homozygotes show shortening of the sec-
ond phalanges and the metaphalanges, especially in
digits 2 and 5, as well as a rudimentary extra digit post-
axial to digit 5 in some cases.) If the patients described
here are indeed haploinsufficient for HOXD13, then the
strikingly different phenotype of these knockout mice
might reflect differences in the role of HOXD13 in mu-
rine and human autopod development. Because this pro-
cess is highly conserved, however, this seems unlikely.
More plausibly, replacement of the mouse gene’s hom-
eobox by the neomycin-resistance cassette might not
produce a simple null Hoxd13 allele, either because the
intact first exon still encodes a functional product (Co-
peland et al. 1996; Hyduk and Percival-Smith 1996) or
because the cassette itself interferes with the regulation
of other 5′ Hoxd genes (Ramı´rez-Solis et al. 1993; Rijli
et al. 1994; Fiering et al. 1995; Olson et al. 1996; Pham
et al. 1996).
Mice heterozygous for a deletion encompassing
Hoxd11, Hoxd12, and Hoxd13 merely have shortening
of digits 2 and 5 (Za´ka´ny and Duboule 1996). (Ho-
mozygotes have phenotypes similar to human SPD het-
erozygotes and homozygotes, including an extra central
digit fused to digit 3 or digit 4.) Although the different,
more severe phenotype of the patients described here
might again reflect differences between murine and hu-
man autopod development, it is also possible that it is
due to the untrammeled action of HOXD11 and
HOXD12, whose effects are thought to be controlled
by HOXD13 during normal autopod development
(Za´ka´ny and Duboule 1996; Rijli and Chambon 1997).
Detailed in vivo studies of the functional effects of the
two deletions reported here will be necessary to resolve
which of the alternative explanations for the observed
phenotype is correct. Whether or not the mutations in-
deed lead to functional haploinsufficiency, however, the
resulting insights into the function of HOXD13 will be
certain to advance our understanding of human limb
development.
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